1. Sánchez-Torres P. et al "Identification of amino acid residues critical for catalysis and stability in Aspergillus niger family 1 pectin lyase A" Biochem J. 2003 Feb 15;370(Pt 1):331-7
2. Lopez-Siles M. et al "Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth" Appl Environ Microbiol. 2012 Jan;78(2):420-8.
3. Weikert T. et al "Reassessment of chitosanase substrate specificities and classification" Nat Commun. 2017 Nov 22;8(1):1698
4. Sánchez-Torres P. et al "Identification of amino acid residues critical for catalysis and stability in Aspergillus niger family 1 pectin lyase A" Biochem J. 2003 Feb 15;370(Pt 1):331-7
5. Glinsky VV1. et al "Modified citrus pectin anti-metastatic properties: one bullet, multiple targets" Carbohydr Res. 2009 Sep 28;344(14):1788-91
6. Nangia-Makker P. et al "Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin"
7. Glinsky VV1. et al "Modified citrus pectin anti-metastatic properties: one bullet, multiple targets" Carbohydr Res. 2009 Sep 28;344(14):1788-91
8. Venzon SS. et al "Physicochemical properties of modified citrus pectins extracted from orange pomace" J Food Sci Technol. 2015 Jul;52(7):4102-12
The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.